Global Wellness Summit Releases 10 Wellness Trends for 2025
In a polarized wellness market, we'll see both "analog wellness" (a great logging off and seizing of pre-digital experiences) and...
Brain
Hyperquake Is Proud to Support Mayfield Brain & Spine in Launching The Brain Tumor Institute at Mayfield
Collaborating to position the Cincinnati region as a top destination for advanced brain tumor care and innovation CINCINNATI, Jan. 28,...
BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs
Advancement of next-generation APJ agonists with discontinuation of azelaprag Nomination of NLRP3 inhibitor BGE-102 as a development candidate, with initial...
Polarean and SimonMed Announce Collaboration to Advance Lung Imaging Innovation
One of the largest US outpatient medical imaging providers to introduce Xenon MRI platform to its network Polarean and SimonMed...
“Longevity Investors Lunch” Held in Davos
Key stakeholders in the longevity field convened at an exclusive Longevity Investors Lunch during the World Economic Forum.Zug, Switzerland--(Newsfile Corp....
Nine Levers Employers Can Use to Improve Brain Health and Workplace Performance
New unified model developed by UsAgainstAlzheimer's, the Davos Alzheimer's Collaborative and the McKinsey Health Institute provides roadmap for employers to...
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
- High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the...
bit.bio Launches ioTracker Cells Range at SLAS 2025, Adding New Visualisation Functionality to Human iPSC-derived Cell Types
Researchers can easily track and isolate bit.bio's consistent, defined, and scalable human iPSC-derived cells for the first time, opening up...
Awakn Life Sciences Provides Update on R&D Programs, Progressing Novel Therapeutics for Alcohol Use Disorder and PTSD
Toronto, Ontario--(Newsfile Corp. - January 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn"...
PreveCeutical Announces Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company"...
Wesana Health Announces Change to The Board of Directors
Chicago, Illinois and Toronto, Ontario--(Newsfile Corp. - January 24, 2025) - Wesana Health Holdings Inc. (CSE: WESA.X) (OTC Pink: WSNAF)...
Positron Corporation Secures Agreement to Sell and Rent Eight NeuSight PET-CT Scanners
Niagara Falls, NY, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular...
Firefly Neuroscience Announces Publications Demonstrating the Utility of Advanced EEG Analytics in Drug Development and Neuropsychiatric Care
Growing body of clinical evidence supports use of Company’s FDA-Cleared BNA™ platform to provide objective measures of drug efficacy and...
BioPorto announces the publication of urinary NGAL reference ranges in healthy adult and pediatric individuals
News Release January 23, 2025 BioPorto announces the publication of urinary NGAL reference ranges in healthy adult and pediatric individuals...
Cancer Research UK, Cytovation and the Norwegian Cancer Society collaborate to advance treatment for rare cancer
Collaboration to take Cytovation’s synthetic peptide, CY-101, into a Phase 2 trial for patients with adrenocortical carcinomaCancer Research UK’s Centre...
Tiziana Life Sciences Announces Discovery of New Immune Biomarkers in Multiple Sclerosis Patients Treated with Nasal Foralumab
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology...
Nalu Expands MRI-Conditional Labeling for Peripheral Nerve Stimulation with FDA Clearance for Whole-Body MRI
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved...
Nalu Expands MRI-Conditional Labeling for Peripheral Nerve Stimulation with FDA Clearance for Whole-Body MRI
CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved...
Biodexa Strengthens Management Team – Appointment of Dr Gary A. Shangold as Chief Medical Officer
January 22, 2025 Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC...
IMMvention Therapeutix Enters Strategic Collaboration with Novo Nordisk to Develop Oral Therapies for Sickle Cell Disease and Other Chronic Diseases
DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing...